Lion's main enhances doxorubicin-induced apoptosis in human hepatocellular carcinoma cells. - GreenMedInfo Summary

Abstract Title:

Hericium erinaceus enhances doxorubicin-induced apoptosis in human hepatocellular carcinoma cells.

Abstract Source:

Cancer Lett. 2010 Nov 28 ;297(2):144-54. PMID: 20554107

Abstract Author(s):

Jong Seok Lee, Eock Kee Hong

Article Affiliation:

Department of Bioengineering and Technology, Kangwon National University, Chuncheon 200-701, Republic of Korea.

Abstract:

It has been demonstrated that the Hericium erinaceus (HE) mushroom, which primarily consists of polysaccharides, possesses anti-tumor activities. However, the mechanisms by which HE inhibits human hepatocellular carcinoma growth remain unknown. Our study demonstrates that HE acts as an enhancer to sensitize doxorubicin (Dox)-mediated apoptotic signaling, and this sensitization can be achieved by reducing c-FLIP expression via JNK activation and enhancing intracellular Dox accumulation via the inhibition of NF-κB activity. These findings suggest that HE in combination with Dox serves as an effective tool for treating drug-resistant human hepatocellular carcinoma.

Pubmed Data : Cancer Lett. 2010 Nov 28 ;297(2):144-54. PMID: 20554107
Article Published Date : Nov 28, 2010
Study Type : In Vitro Study
Additional Links
Substances : Lion's Mane (Hericium Erinaceus) : CK(41) : AC(18)
Diseases : Liver Cancer : CK(1577) : AC(266)
Pharmacological Actions : Apoptotic : CK(1416) : AC(1089), Chemosensitizer : CK(188) : AC(156)
Additional Keywords : Drug: Doxorubicin : CK(140) : AC(54)

Print Options

Some features are currently member only features. If you are already a member, please login. Otherwise, click here to become a member.

Login to Comment

Commenting is limited to Members only. If you are already a member, please login to post a comment. If you do not have a member account and would like to become a member, please click here to begin the process to become a member.